R
Market Data
$26.93−$3.69 (−12.05%)
RAPP · Last trade
Prev Close
$30.62
Range (30d)
$25.97 – $30.93
Recent Filings
- 8-K195.7 KBRapport Therapeutics, Inc.Jan 7, 8:35 AM ET·0001193125-26-005499
- 8-K25.6 MBRapport Therapeutics, Inc.Jan 7, 7:30 AM ET·0001193125-26-005446
- 10-Q10.3 MBRapport Therapeutics, Inc.Nov 6, 7:30 AM ET·0001193125-25-268096
- 8-K478.4 KBRapport Therapeutics, Inc.Nov 6, 7:15 AM ET·0001193125-25-268072
- 8-K446.5 KBRapport Therapeutics, Inc.Sep 10, 5:22 PM ET·0001193125-25-200205
- 8-K142.8 KBRapport Therapeutics, Inc.Sep 8, 4:02 PM ET·0001193125-25-198322
- 8-K10.8 MBRapport Therapeutics, Inc.Sep 8, 6:12 AM ET·0001193125-25-197610
- 10-Q10.2 MBRapport Therapeutics, Inc.Aug 7, 7:30 AM ET·0000950170-25-104565
- 8-K19.3 MBRapport Therapeutics, Inc.Aug 7, 7:15 AM ET·0000950170-25-104557
- 8-K182.7 KBRapport Therapeutics, Inc.Jun 18, 4:30 PM ET·0000950170-25-087921
Insiders
10- ARCH Venture Fund XII, L.P.10% Owner
- Bredt DavidChief Scientific Officer
- Burow Kristina10% Owner
- Burrell Terry-AnnDirector
- Ceesay AbrahamDirector, Chief Executive Officer
- CRANDELL KEITH10% Owner
- Galer Bradley S.Chief Medical Officer
- Gault CherylChief Operating Officer
- GILLIS STEVEN10% Owner
- HEALY JAMESDirector
Tickers
Addresses
business
99 HIGH STREET SUITE 2100
BOSTON, MA, 02110
mailing
99 HIGH STREET SUITE 2100
BOSTON, MA, 02110
Former Names
- Rapport Therapeutics, Inc.2026-01-07